Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain
Authors
Keywords
HIV epidemiology, HIV, Antiretroviral therapy, Spain, Cost-effectiveness analysis, AIDS, HIV diagnosis and management, HIV infections
Journal
PLoS One
Volume 13, Issue 11, Pages e0206755
Publisher
Public Library of Science (PLoS)
Online
2018-11-06
DOI
10.1371/journal.pone.0206755
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016
- (2017) Santiago Moreno et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults
- (2017) Antonio Rivero et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Costes de la tuberculosis en España: factores relacionados
- (2016) José Antonio Gullón et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults
- (2016) Juan Berenguer et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Analysis of contemporary HIV/AIDS health care costs in Germany
- (2016) Marina Treskova et al. MEDICINE
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission
- (2016) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Costes de la tuberculosis en España: factores relacionados
- (2016) José Antonio Gullón et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement: a modelling study
- (2016) Maunank Shah et al. Lancet HIV
- Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain
- (2016) Eliazar Sabater et al. Applied Health Economics and Health Policy
- Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain)
- (2015) Julieta Corral et al. BMC HEALTH SERVICES RESEARCH
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of a European ST-segment elevation myocardial infarction network: results from the CatalanCodi Infartnetwork
- (2015) Ander Regueiro et al. BMJ Open
- Thresholds for the cost–effectiveness of interventions: alternative approaches
- (2015) Elliot Marseille et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Projected Lifetime Healthcare Costs Associated with HIV Infection
- (2015) Fumiyo Nakagawa et al. PLoS One
- Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences
- (2014) Jesus Martín-Fernández et al. BMC HEALTH SERVICES RESEARCH
- Cost of Disorders of the Brain in Spain
- (2014) Oleguer Parés-Badell et al. PLoS One
- The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States
- (2013) Elisa F. Long et al. ANNALS OF INTERNAL MEDICINE
- Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness
- (2013) Yazdan Yazdanpanah et al. PLoS One
- Replacing Clinic-Based Tests With Home-Use Tests May Increase HIV Prevalence Among Seattle Men Who Have Sex With Men
- (2013) David A. Katz et al. SEXUALLY TRANSMITTED DISEASES
- The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression
- (2012) Amanda Mocroft et al. ANTIVIRAL THERAPY
- Prevalence of undiagnosed HIV infection in the general population having blood tests within primary care in Madrid, Spain: Table 1
- (2012) Santiago Moreno et al. SEXUALLY TRANSMITTED INFECTIONS
- Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata
- (2011) Joanne Reekie et al. AIDS
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of Quality-Adjusted Life-Years in the Economic Evaluation of Health Technologies in Spain: A Review of the 1990–2009 Literature
- (2011) José Manuel Rodriguez et al. VALUE IN HEALTH
- Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
- (2010) Deborah Donnell et al. LANCET
- Estimating the Impact of Plasma HIV-1 RNA Reductions on Heterosexual HIV-1 Transmission Risk
- (2010) Jairam R. Lingappa et al. PLoS One
- Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness
- (2010) Yazdan Yazdanpanah et al. PLoS One
- Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009
- (2010) T. Brown et al. SEXUALLY TRANSMITTED INFECTIONS
- Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Studies
- (2010) Marcel Wolbers et al. PLOS MEDICINE
- Time taken to undetectable viral load, following the initiation of HAART
- (2009) S Currie et al. INTERNATIONAL JOURNAL OF STD & AIDS
- HIV-1 Transmission, by Stage of Infection
- (2008) T. Déirdre Hollingsworth et al. JOURNAL OF INFECTIOUS DISEASES
- Bayesian melding for estimating uncertainty in national HIV prevalence estimates
- (2008) L Alkema et al. SEXUALLY TRANSMITTED INFECTIONS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started